Bayer has said it is shifting the focus of its pharmaceutical business to the US and away from Europe and the UK, where governments are making “big mistakes” in how they manage health budgets.
拜耳(Bayer)表示，将把制药业务的重心从欧洲和英国转移到美国。欧洲和英国政府在管理医疗预算方面犯了“重大错误”。
您已阅读4%（250字），剩余96%（6078字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。